Is the Adderall shortage still affecting patients in 2026, and which brand-name or generic versions remain difficult to find at pharmacies? What are the latest updates on manufacturing delays, supply chain problems, and prescription demand that continue to impact ADHD medication availability? And what steps can patients take with their healthcare providers to manage treatment, find alternatives, or handle prescription shortages safely?